Latest Articles
Real-time emergency wait list portal live in Queensland and more briefs - Healthcare IT News
Real-time emergency wait list portal live in Queensland and more briefs Healthcare IT News
Published: Feb. 7, 2025, 3:49 a.m.
Michigan health system halts gender-affirming care for minors after Trump order - MLive.com
Michigan health system halts gender-affirming care for minors after Trump order MLive.com
Published: Feb. 6, 2025, 7:57 p.m.
Michigan health system halts new gender-affirming care for minors after Trump order - MLive.com
Michigan health system halts new gender-affirming care for minors after Trump order MLive.com
Published: Feb. 6, 2025, 7:57 p.m.
Endometriosis Clinical Trials and Studies 2025: EMA, PDMA, FDA - openPR
Endometriosis Clinical Trials and Studies 2025: EMA, PDMA, FDA openPR
Published: Feb. 6, 2025, 7:24 p.m.
Policy Expert joins endometriosis-friendly employer scheme - Employee Benefits
Policy Expert joins endometriosis-friendly employer scheme Employee Benefits
Published: Feb. 6, 2025, 12:27 p.m.
Is the 'Ozempic baby' phenomenon real? Experts share thoughts - India Today
Is the 'Ozempic baby' phenomenon real? Experts share thoughts India Today
Published: Feb. 6, 2025, 4:12 a.m.
Remakes 2025: Films and tv shows getting remade - The Australian Women's Weekly
Remakes 2025: Films and tv shows getting remade The Australian Women's Weekly
Published: Feb. 5, 2025, 11:12 p.m.
ASCO Reading Room | Is the End of Systemic Chemotherapy Near for Advanced Endometrial Cancer? - Medpage Today
ASCO Reading Room | Is the End of Systemic Chemotherapy Near for Advanced Endometrial Cancer? Medpage Today
Published: Feb. 5, 2025, 7:31 p.m.
Christian Marth on a First-Line Chemotherapy-Free Option for Advanced Endometrial Cancer - Medpage Today
Christian Marth on a First-Line Chemotherapy-Free Option for Advanced Endometrial Cancer Medpage Today
Published: Feb. 5, 2025, 5:54 p.m.
First-Line Lenvatinib Plus Pembrolizumab Versus Chemotherapy for Advanced Endometrial Cancer: A Randomized, Open-Label, Phase III Trial - Medpage Today
First-Line Lenvatinib Plus Pembrolizumab Versus Chemotherapy for Advanced Endometrial Cancer: A Randomized, Open-Label, Phase III Trial Medpage Today
Published: Feb. 5, 2025, 5:54 p.m.
Link copied to clipboard!